AcuityMD Embeds AI into Salesforce to Supercharge MedTech Sales

BOSTON, MA – February 18, 2026 – In a move set to reshape how medical technology reaches the market, AI-driven intelligence platform AcuityMD has launched its native application on the Salesforce AppExchange. The new offering, ‘AcuityMD for Salesforce,’ directly integrates the company’s specialized MedTech commercialization platform into the world’s leading CRM, promising to arm sales teams with unprecedented efficiency and insight.

The launch addresses a long-standing challenge in the multi-billion-dollar medical device industry: the disconnect between powerful market intelligence and the daily workflows of commercial teams. By embedding its AI-powered data directly within the Salesforce environment, AcuityMD aims to dissolve data silos, automate cumbersome manual processes, and empower sales representatives to identify and act on high-value opportunities with greater speed and precision.

Streamlining the MedTech Sales Machine

For MedTech commercial teams, the field is a complex landscape of hospitals, surgical centers, and private practices. Identifying which physicians are performing relevant procedures, understanding their patient volumes, and tracking their affiliations has traditionally involved painstaking manual research across disparate, often outdated databases. This administrative burden eats into valuable time that could be spent building relationships and closing deals.

The AcuityMD for Salesforce integration is designed to eliminate this friction. It creates a seamless, two-way data sync between AcuityMD’s rich, MedTech-specific intelligence and a company’s Salesforce instance. This alignment of targeting, account, and opportunity data into a single, unified workflow means sales reps no longer need to toggle between systems or manually update records. The platform delivers an automated feed of new opportunities directly into the CRM they already use every day.

This integration allows a sales representative to operate entirely within their existing Salesforce processes while benefiting from AcuityMD's insights. For example, the system can automatically flag a surgeon who has recently increased their volume of a specific procedure, presenting a prime opportunity for a new medical device. It can also map out entire networks of care, revealing referral patterns and key decision-makers that were previously obscured. By automating these insights, the platform enables teams to prioritize the right accounts and accelerate opportunities through the sales pipeline with newfound clarity.

A Strategic Leap for a Rising AI Star

The launch on the Salesforce AppExchange is more than a product update; it is a significant strategic maneuver for AcuityMD. The company, founded in 2019, has been on a meteoric rise, securing over $83 million in funding and earning a coveted spot on Forbes' 2025 "Next Billion-Dollar Startups" list. This integration is a critical step in solidifying that trajectory.

By tapping into the vast Salesforce ecosystem, AcuityMD dramatically expands its market reach, making its powerful toolset accessible to the thousands of MedTech companies that already rely on Salesforce as their system of record. It lowers the barrier to adoption and entrenches AcuityMD’s platform as an indispensable component of the modern MedTech commercial stack. Success stories from its existing 400-plus clients, which include eight of the top ten global MedTech giants, already point to the platform's impact, with some users reporting sales growth of over 25% and contributing to a pipeline of over $10 billion.

“We’re excited to partner with Salesforce to bring AcuityMD for Salesforce to AppExchange,” said Alex Wakefield, Chief Revenue Officer at AcuityMD, in a press statement. “This launch helps MedTech teams work more efficiently in the systems they already use, while giving them clearer visibility into their highest-value opportunities.” This move reinforces AcuityMD’s competitive advantage, shifting it from a standalone intelligence tool to a deeply integrated workflow solution.

The Power of Purpose-Built Data

What sets AcuityMD apart from generic sales intelligence platforms is its laser focus on the MedTech industry and its unique data assets. The platform’s AI engine is fueled by real-world, de-identified healthcare data from over 325 million patients. It analyzes this vast dataset to provide granular insights that are directly relevant to medical device sales, such as surgical volumes, historical product usage, and provider affiliations.

This purpose-built approach has yielded tangible results. For example, Embody, Inc. used AcuityMD to refine its commercial strategy, ultimately generating over $3 million in new sales and helping pave the way for its acquisition by Zimmer Biomet. Similarly, global powerhouse Becton, Dickinson and Company (BD) expanded its use of the platform to over 300 users across two divisions, replacing manual analysis with real-time insights to drive market share growth.

By bringing this specialized data directly into Salesforce, AcuityMD enables a level of targeting that was previously impossible for many organizations. Instead of casting a wide net, sales teams can now pinpoint the exact physicians and sites of care that represent the most significant addressable opportunity, armed with data to support their outreach.

Navigating the Path to Integrated Intelligence

While the promise of a fully integrated, AI-powered commercial workflow is compelling, the path to implementation is not without its challenges. The successful adoption of AcuityMD for Salesforce will require more than just technical integration; it demands a commitment to change management within sales organizations. Teams will need training to move away from old habits and fully leverage the new, data-driven workflows.

Furthermore, the handling of healthcare data, even when de-identified, operates under intense scrutiny. Maintaining robust security protocols and ensuring continuous compliance with regulations like HIPAA is paramount for both AcuityMD and its customers, especially as data flows between two major enterprise platforms.

For global MedTech companies, another consideration is data availability. While AcuityMD’s current strength lies in the U.S. market, its effectiveness in international territories will depend on its ability to source and integrate high-quality healthcare data from those regions. Despite these hurdles, the launch represents a significant evolution in healthcare commercialization. It signals a shift away from intuition-based selling toward a more scientific, data-driven approach, ultimately accelerating the process of getting innovative and life-saving medical technologies into the hands of the providers who need them most.